This is a federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, identified as 36F79723D0016|36C24725N0794, is for the provision of the Optune Plus Transducer medical device system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. The contract has a ceiling value of...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract, valued at $49,748.73, is for the provision of Novocure's Optune system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. The contract is part of Novocure's Federal Supply Schedule...
This $99,497.46 firm fixed-price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the delivery of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to VA medical centers. Novocure's proprietary Optune system delivers alternating electric...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 firm-fixed-price delivery order is for the provision of Novocure's Optune Plus transducer devices, which deliver Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma in veteran patients. The award is part of a larger $28.85 million Federal...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The $49,748.73 contract is for the delivery of Novocure's Optune system, a medical device that utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. This contract is part of Novocure's larger $28.85 million Federal...
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is for the provision of Novocure's proprietary Optune Plus transducers, which deliver Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma. The contract is a firm-fixed-price purchase order with a period of performance...
This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $33,165.82, is a firm fixed-price purchase order for the delivery of Novocure's Optune system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers such as glioblastoma and mesothelioma. The contract does not have a set-aside designation,...
This is a federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract is for the provision of Novocure's Optune Plus transducer devices, which utilize Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma, in VA medical facilities. The contract, which has a ceiling value of $49,748.73 and runs...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract, with a ceiling value of $49,748.73, is for the provision of Optune Plus Transducers, a proprietary medical device system that utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. This contract is a delivery order under...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $49,748.73, is for the delivery of Optune Plus transducers, a component of Novocure's Tumor Treating Fields (TTFields) therapy devices used to treat glioblastoma and mesothelioma. The contract is a delivery order issued under Novocure's 5-year Federal Supply Schedule (FSS)...